Elevance Health (ELV) Expands Health OS, Is The Stock Fully Valued?

Simply Wall St.06-25

Elevance Health (ELV) recently highlighted new capabilities in its Health OS platform, connecting directly with electronic health records and Epic’s Payer Platform to simplify clinical review, prior ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646392843?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","is_english":true,"pubTime":"2026-06-25 02:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646392843","market":"us","top_or_hot":-1,"title":"Elevance Health (ELV) Expands Health OS, Is The Stock Fully Valued?","media":"Simply Wall St.","content":"<div>\n<p>Elevance Health (ELV) recently highlighted new capabilities in its Health OS platform, connecting directly with electronic health records and Epic’s Payer Platform to simplify clinical review, prior ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-expands-health-os-is-the-stock-fully-val\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elevance Health (ELV) Expands Health OS, Is The Stock Fully Valued?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElevance Health (ELV) Expands Health OS, Is The Stock Fully Valued?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-25 02:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-expands-health-os-is-the-stock-fully-val><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elevance Health (ELV) recently highlighted new capabilities in its Health OS platform, connecting directly with electronic health records and Epic’s Payer Platform to simplify clinical review, prior ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-expands-health-os-is-the-stock-fully-val\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237957811.SGD","symbol_name":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-expands-health-os-is-the-stock-fully-val","article_id":"2646392843","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-expands-health-os-is-the-stock-fully-val","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2646392843","pubTimestamp":1782326048,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Elevance Health (ELV) recently highlighted new capabilities in its Health OS platform, connecting directly with electronic health records and Epic’s Payer Platform to simplify clinical review, prior authorization, and care coordination for providers and members.\nSee our latest analysis for Elevance Health.\nThese Health OS upgrades come as Elevance Health’s share price sits at US$395.10, with a 90-day share price return of 33.44% and a 1-year total shareholder return of 7.17%. The 3-year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","BK4588":"碎股","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","BK4154":"管理型保健护理","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0882574055.USD":"富达全球健康医疗A ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","ELV.AU":"ELEVRA LITHIUM LTD","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0251142724.SGD":"Fidelity America A-SGD","SG9999001077.SGD":"United International Growth Fund SGD","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4585":"ETF&股票定投概念","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","ELV":"Elevance Health","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC"},"translate_title":"Elevance Health(ELV)扩展Health OS，股票估值充分吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1.5,"ELV.AU":1.5},"content_text":"Elevance Health (ELV) recently highlighted new capabilities in its Health OS platform, connecting directly with electronic health records and Epic’s Payer Platform to simplify clinical review, prior authorization, and care coordination for providers and members. See our latest analysis for Elevance Health. These Health OS upgrades come as Elevance Health’s share price sits at US$395.10, with a 90-day share price return of 33.44% and a 1-year total shareholder return of 7.17%. The 3-year total shareholder return shows a decline of 6.64%, indicating improving recent momentum after a weaker multi year stretch. If you are weighing Elevance Health alongside other healthcare technology stories, this is a good moment to look at companies using AI in care delivery and operations through the 38 healthcare AI stocks With Elevance Health trading at US$395.10 after a strong 90 day run, the key question is whether the Health OS and digital programs are already fully reflected in the valuation, or whether the recent momentum still leaves a genuine opportunity that markets have not fully priced in. AdvertisementMost Popular Narrative: 2% Overvalued Compared with the narrative fair value estimate of $387.85, Elevance Health’s last close at $395.10 sits modestly above that mark, which frames how analysts are thinking about the stock’s risk and reward trade off.  Analysts are assuming Elevance Health's revenue will grow by 6.8% annually over the next 3 years. Analysts assume that profit margins will increase from 2.8% today to 3.2% in 3 years time.  Read the complete narrative. The fair value hinges on a specific earnings roadmap, steady margin rebuild, and a future valuation multiple below many peers. Want to see exactly how those pieces fit together? Result: Fair Value of $387.85 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, Elevance Health still faces real pressure from elevated medical cost trends and shifting Medicare Advantage and ACA policies, which could cap margins and challenge the current narrative. Find out about the key risks to this Elevance Health narrative. Another View: Elevance Health Through Earnings Multiples While the narrative fair value puts Elevance Health at $387.85 and labels the stock as modestly overvalued at $395.10, the earnings multiple story points in a different direction. A current P/E of 16.4x is described as good value versus both a 30.7x fair ratio and a 23.1x industry average, with peers around 38.6x. For investors, that gap raises a simple question: is the market underpricing Elevance Health’s earnings power or correctly discounting policy and growth risks? See what the numbers say about this price — find out in our valuation breakdown. NYSE:ELV P/E Ratio as at Jun 2026Next Steps If the mixed signals around Elevance Health have you on the fence, act while the data is fresh and weigh the company’s strengths for yourself through the 4 key rewards Looking for more investment ideas beyond Elevance Health? Elevance Health may be on your radar today, but you do not want to stop there when other compelling stock ideas are just a few clicks away.  Target dependable cash generation with companies that pair quality earnings with attractive pricing through the 44 high quality undervalued stocks Strengthen your income stream by focusing on businesses built around robust, higher yielding payouts using the 7 dividend fortresses Prioritise resilience by scanning for companies that score well on stability and risk through the 67 resilient stocks with low risk scores   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Elevance Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646392843","isCrawlerRequest":true}